The Department of Veterans Affairs, a provider of health care to more than 5 million people, said it will cease using Roche AG’s Avastin to treat an eye disease as it investigates reports of serious infections and blindness.
Regeneron Pharmaceuticals Inc. shares surged to a 20-year high on a Department of Veterans Affairs decision to stop using Roche AG’s cancer drug Avastin to treat an eye disease as it investigates reports of serious infections and blindness.
President Barack Obama today backed his health secretary’s decision to overrule U.S. drug regulators and deny Teva Pharmaceutical Industries Ltd.’s request to sell its emergency contraceptive pill Plan B over the counter.
Drugmaker executives whose companies promote unauthorized uses of their medicines may be targeted by U.S. regulators for misdemeanor prosecutions, Food and Drug Administration Deputy Chief for Litigation Eric Blumberg said.
Expanding U.S. state Medicaid programs may contribute to reduced death rates, as the poor, elderly and other vulnerable people benefit from greater access to health care, Harvard University researchers said in a report.